-
Targeted substances
- Triglyceride
- Bilirubin
- Carbamazepine
- Digoxin
- Methotrexate
- Bile acid
- Paraquat
- Myoglobin
- Cholesterol
- Inflammatory Mediators and Cytokines
- Leptin
- Ammonia
- Protein-bound toxins
- β2-MG
- Organophosphate
- PTH
- Rivaroxaban
- 2,4-dinitrophenol
- Ticagrelor
- Paracetamol
- Metformin
- ANA and ds-DNA titers
- Abrin
- Sodium valproate
- Amlodipine
- Estazolam
- Quetiapine
- Olanzapine
- Ziprasidone
- Vancomycin
- Organophosphorus
- Circulating Bacteria
- Liver Enzymes(e.g. ALT,AST)
- Vancomycin
- Gentamicin
- Poison
- Protein binded substance
- Antimicrobials
- Others
-
Benefits
- Improve QOL
- Decrease Vasopressor Needs
- Stabilize Hemodynamics
- Improve oxygenation
- Bridge to Liver Transplantation
- Reduce the incidence of adverse effect
- Shorten ICU stay
- Reduce bleeding complications
- Reduce Mechanical Ventilation
- Improve Respiratory Function
- Lower the mortality rate
- Improve Liver Function
- Improve sleep efficiency
- Improve HE
- Improve renal function
- Relieve Uremic Pruritis
- Reduce Cardiovascular Related Events
- Improve Survival Rate
- Remove inflammatory markers/ cytokines
- Reduce circulating bacterial load
- Improve disease symptoms
- Improve laboratory parameters
- Others
- Disease
- Endocarditis
- Poisoning/Drug overdose
- Leptospirosis
- Sepsis/ Septic Shock
- Multiple Myeloma
- Severe Acute Pancreatitis(SAP)
- Multiple Organ Dysfunction Syndrome(MODS)
- Rhabdomyolysis
- Dengue
- Leukemia-Sepsis
- Burn
- Trauma
- Open Heart Surgery
- Acute Respiratory Distress Syndrome (ARDS)
- Hepatic Encephalopathy(HE)
- End Stage Renal Disease(ESRD)
- Acute Kidney Injury(AKI)
- Systemic Lupus Erythematosus (SLE)
- Liver Transplantation
- Liver Failure(LF)
- Jaudice
- Subarachnoid Hemorrhage
- Symmetrical Peripheral Gangrene(SPG)
- Wasp Stings
- Acute Renal Failure
- Hepatitis
- Cardiopulmonary Bypass(CPB)
- Severe Liver Injury
- Henoch-Schönlein purpura (HSP)
- COVID-19
- Polymyositis
- Liver Cirrhosis
- Hyperbilirubinemia
- Maintenance Hemodialysis (MHD)
- Crush syndrome
- Human Immunodeficiency Virus(HIV)
- Immunological diseases (IMD)
- Hyperlipidemia
- Infection
- Others
-
The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study.
Surasit, K., & Srisawat, N. (2022). Blood Purification, 1-10.
-
Can the Reduction of Cytokines Stop the Progression of Sepsis?
Koc, S., Celebi, S., Hanikoglu, F., Polat, Y., Uysal, B. B., Dokur, M., ... & Kupeli, İ. (2022). Cureus, 14(2).
-
Additional hemoperfusion is associated with improved overall survival and self-reported sleep disturbance in patients on hemodialysis.
Gu, Y. H., Yang, X. H., Pan, L. H., Zhan, X. L., Guo, L. L., & Jin, H. M. (2019). The International Journal of Artificial Organs, 42(7), 347-353
-
Acute abrin poisoning treated with continuous renal replacement therapy and hemoperfusion successfully
Huang, J., Zhang, W., Li, X., Feng, S., Ye, G., Wei, H., & Gong, X. (2017).Medicine, 96(27).
-
POS-854 NEGATIVE ALACTIC VALUE IS REVERSED BY HEMOPERFUSION IN SEPTIC PATIENTS
Guido, C. M., Pablo, J. C., Martinez, G. A., et al. Kidney International Reports, 2022, 7(2), S369.
-
POS-568 CLINICAL OBSERVATION OF FRACTIONATED PLASMA SEPARATION AND ADSORPTION MODE INTEGRATED WITH CONTINUOUS VENO-VENOUS HAEMOFILTRATION APPLIED IN THE TREATMENT OF PATIENTS WITH SEVERE POISONING
DONG J, Li C, Huang L, Wu B, Fan W, Huang L, Ge Y. Kidney International Reports (2022) 7, S1–S436.
-
POS-855 MORTALITY RATE AND ACUTE KIDNEY INJURY PREVALENCE REDUCTION IN COVID-19 CRITICAL PATIENTS TREATED WITH HEMOPERFUSION
Lozano-Sanchez M, Pablo J C, Aroca-Martinez G, et al. Kidney International Reports, 2022, 7(2): S369.
-
The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis
Bai W, Yao C, Mao D, Wu J, Wang K, Wei H, Huang Z, Shi Q, Wang N. J Healthc Eng. 2022 Mar 25;2022:3139929.
-
Bilirubin adsorption for the treatment of severe hyperbilirubinemia after cardiac surgery: A retrospective cohort study
Chen X, Li L, Bai M, Sun S, Chen X. Int J Artif Organs. 2022 Feb;45(2):146-151.
-
POS-875 THE CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH COVID 19 WHO UNDERWENT HEMOPERFUSION IN BATAAN GENERAL HOSPITAL AND MEDICAL CENTER
Siasat A, Ilagan B C, Reyes A, et al. Kidney International Reports, 2022, 7(2): S378-S379.
-
Meta-Analysis of the efficacy of DPMAS-based articial liver in the treatment of ACLF
L Ma, X Zhang, W Ma, X Ding.2022.researchsquare.com
-
The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass.
He, Z., Lu, H., Jian, X., Li, G., Xiao, D., Meng, Q., ... & Zhou, C. (2022). Blood Purification, 51(1), 31-37.
-
An incident of chloroform poisoning on a university campus
Cui, Si-Qi et al. World journal of emergency medicine vol. 13,2 (2022): 155-157.
-
SUCCESSFUL TREATMENT OF AN END-STAGE KIDNEY DISEASE PATIENT PRESENTING WITH SEVERE COVID-19 DISEASE USING ENHANCED CYTOKINE REMOVAL WITH HAEMOADSORPTION THERAPY IN ADDITION TO STANDARD MANAGEMENT
Tan, E. Z. Z., & Wong, H. S. (2022). Journal of Clinical and Translational Nephrology, 1.
-
COMBINED EXTRACORPOREAL BLOOD PURIFICATION IN A PATIENT WITH SEVERE COVID-19 AND SEPTIC SHOCK
Avetisyan EA, Merkulova IA, Pevsner DV, Pokrovskiy SN.38th Vicenza Course on AKI&CRRT
-
HEMOPERFUSION IN ERC5D PATIENT WITH SEPSIS PICTURE DUE TO ACUTE INTERSTITIAL PNEUMONIA SECONDARY TO SARS COV 2 (COVID 19) INFECTION
Salomé, Jorge, Panta, Marilyn, Duque. Jessica, Médico Nefrólogo, Specialist nurses
-
COMPARISON OF DEATH ODDS RATIO IN PATIENTS WITH COVID-19 IN GROUPS WITH CONSERVATIVE THERAPY AND AFTER CYTOKINE ADSORPTION
Nogaibayeva A., Zhunussov A., Ivanov Y., Kanafina Sh., Vakhrushev I. Jabayeva N., Udalova A. 38th Vicenza Course on AKI&CRRT
-
EFFECT OF EXTRACORPOREAL HEMOPERFUSION REMOVAL OF INFLAMMATORY MEDIATORS AND SURVIVAL IN END STAGE LIVER DISEASE PATIENTS WITH SEPTIC SHOCK
Dinesh Devarajan, Akila Rajakumar, Dinesh Jothimani, Jagdish K. 38th Vicenza Course on AKI&CRRT
-
ECBP IN CRITICALLY ILL SEPTIC PATIENTS
E. Chrysanthopoulou, A. Armaganidis. 38th Vicenza Course on AKI&CRRT
-
THERAPEUTICAL APPROACH OF HA330 ABSORBER IN CASE OF SEPSIS IN CHILDREN
Askhat Saparov, Zaure Tobylbayeva, Ramazan Abylkassov, Samat Issakov, Vitaliy Sazonov. 38th Vicenza Course on AKI&CRRT